(19)
(11) EP 2 562 183 A8

(12) CORRECTED EUROPEAN PATENT APPLICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 A1)

(48) Corrigendum issued on:
08.05.2013 Bulletin 2013/19

(88) Date of publication A3:
27.02.2013 Bulletin 2013/09

(43) Date of publication:
27.02.2013 Bulletin 2013/09

(21) Application number: 12191623.3

(22) Date of filing: 25.07.2008
(27) Previously filed application:
 25.07.2008 PCT/EP2008/006153
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
C12N 9/90(2006.01)
A61K 39/00(2006.01)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 27.07.2007 EP 07014797
31.07.2007 US 953161 P

(62) Application number of the earlier application in accordance with Art. 76 EPC:
08785106.9 / 2183278

(71) Applicant: Immatics Biotechnologies GmbH
72076 Tübingen (DE)

(72) Inventors:
  • Singh, Harpreet
    72072 Tuebingen (DE)
  • Schoor, Oliver
    72070 Tübingen (DE)
  • Trautwein, Claudia
    42489 Wülfrath (DE)
  • Hilf, Norbert
    72138 Kirchentellinsfurt (DE)
  • Weinschenk, Toni
    73773 Aichwald (DE)
  • Walter, Steffen
    72764 Reutlingen (DE)
  • Lewandrowski, Peter
    72070 Tuebingen-Hirschau (DE)

(74) Representative: Krauss, Jan 
Boehmert & Boehmert Pettenkoferstrasse 20-22
80336 München
80336 München (DE)

 
Remarks:
This application was filed on 07-11-2012 as a divisional application to the application mentioned under INID code 62.
 


(54) Novel immunogenic epitopes for immunotherapy


(57) The present invention relates to amino acid sequences of peptides derived from tumour associated antigens that are able to bind to MHC complexes of either class, and elicit an immune response, as well as to uses of said peptides for the treatment of diseases.